Imperagen raises $6.7M Seed (United Kingdom, May 2026)
$6.7M
£5 millionGenerated social card
Headline
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering - TechCrunch
About
Imperagen is a biotech company focused on enzyme engineering, utilizing quantum physics and AI to enhance the speed and efficiency of enzyme development. The company aims to revolutionize the traditional trial-and-error methods in enzyme engineering, making the process faster and more commercially viable for various industries, including pharmaceuticals and agriculture.
Article summary
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering TechCrunch
Founder
Dr. Andrew Currin, Dr. Tim Eyes, Dr. Andy Almond
Co-founders
Investors · 3
1 hiddenRelated rounds
| May 23, 2026 | Vertical Aerospace | $850.0M | — | United Kingdom |
| May 22, 2026 | QuberTech | $4.3M | — | United Kingdom |
| May 22, 2026 | Scope | $18.4M | — | United Kingdom |
| May 22, 2026 | Happl | $11.0M | Series A | United Kingdom |